Freedom Broker downgraded Inuvo to Hold from Buy with a price target of $2.50, down from $4.20, after the company reported weak Q1 results, significantly missing the firm's estimates "across nearly all metrics." The current financial weakness appears to be the price of business restructuring, while the 2026 investment case "increasingly depends on management's ability to monetize IntentKey and stabilize margins," the analyst tells investors.
